Patient Characteristics
| Characteristic | Cohort 1 | Cohort 2 | Cohort 3 | Overall |
|---|---|---|---|---|
| Number of patients | 10 | 25 | 11 | 46 |
| Sex (n) | ||||
| Female | 5 | 12 | 6 | 23 |
| Male | 5 | 13 | 5 | 23 |
| Age (y) | ||||
| Range | 26–83 | 33–80 | 44–78 | 26–83 |
| Median | 67 | 60 | 63 | 64 |
| Diagnosis (n) | ||||
| Breast cancer | 1 | 5 | 3 | 9 |
| Head/neck cancer | 0 | 0 | 8 | 8 |
| Sarcoma | 2 | 6 | 0 | 8 |
| Cholangiocarcinoma | 4 | 1 | 0 | 5 |
| Prostate cancer | 1 | 4 | 0 | 5 |
| HCC | 1 | 2 | 0 | 3 |
| Colon cancer | 0 | 2 | 0 | 2 |
| Pancreatic cancer | 1 | 1 | 0 | 2 |
| Lung cancer | 0 | 2 | 0 | 2 |
| Testicular cancer | 0 | 1 | 0 | 1 |
| Mesothelioma | 0 | 1 | 0 | 1 |
| Average administered activity (MBq) | 228 ± 51 | 218 ± 41 | 212 ± 38 | 219 ± 43 |
| Average uptake time (min) | 59 ± 3.9 | 62.4 ± 8.8 | 61.6 ± 5.3 | 61 ± 7.4 |
| Average time between 18F-FDG and 68Ga-FAP-2286 PET (d) | 40 ± 24 | 42 ± 27 | 50 ± 35 | 44 ± 24 |